Saturday, July 18, 2026
HomeIndustriesBiotechnology

Biotechnology

Aligos Presents Update of Chronic Hepatitis B Pipeline Portfolio at HEP DART 2021

Aligos Therapeutics, Inc. a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, announced...

EyePoint Pharmaceuticals and Harrow Health’s ImprimisRx Announce Expanded U.S. Commercial Alliance for DEXYCU®

EyePoint Pharmaceuticals, Inc. a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, and...

Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001

Valneva SE a specialty vaccine company, announced the signing of an advance purchase agreement with the Kingdom of Bahrain for the supply of one...

Tune Therapeutics Launches with Pioneering Epigenomic Control Platform to Master Gene Networks, Treat Broad Range of Diseases

Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology...

RemeGen’s Telitacicept and Disitamab Vedotin Enter China’s National Reimbursement Drug List for SLE and Gastric Cancer Treatment

RemeGen Co., Ltd., a commercial-ready biotechnology company, announced that two of its innovative drugs, a dual-targeted TACI-Fc fusion protein, Telitacicept (RC18) for treating systemic...

Hot Topics